Entecavir treatment of hepatitis B virus-infected patients with severe renal impairment and those on hemodialysis.

Kazuharu SuzukiGoki SudaYoshiya YamamotoKen FuruyaMasaru BabaMegumi KimuraOsamu MaeharaTomoe ShimazakiKoji YamamotoTaku ShigesawaAkihisa NakamuraMasatsugu OharaNaoki KawagishiMasato NakaiTakuya ShoMitsuteru NatsuizakaKenichi MorikawaKoji OgawaNaoya Sakamotonull null

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2019)

Entecavir for HBV-infected patients with severe renal dysfunction, including hemodialysis patients, is highly effective and does not affect renal function.

Keyphrases

hepatitis b virus
liver failure
early onset
oxidative stress
chronic kidney disease
peritoneal dialysis
end stage renal disease